The man who discovered ibuprofen Ibuprofen is one of the world’s best selling anti-inflammatory painkillers. Its pioneer, Stewart Adams, now 92 years old, tells Julia Robinson about how and why his discovery came to fruition.…
Chronic Kidney Disease – Mineral and Bone Disorder: pathophysiology and treatment How the pathophysiological mechanisms behind development of Chronic Kidney Disease - Mineral and Bone Disorder can be managed, using appropriate therapeutic interventions to prevent complications.…
How to win national recognition through rheumatology ‘I Love My Pharmacist’ winner Emily Rose has saved the NHS £200,000 as a result of her new patient monitoring pathway. Here she tells Julia Robinson how she accidently fell into rheumatology, and why she intends on rolling the service out to other departments.…
Gene editing used to treat muscular dystrophy in mice CRISPR/Cas9 system injected into muscle or bloodstream restored function of dystrophin gene, marking an important step in gene therapy research.…
Higher doses of vitamin D heighten risk of falls in older people Older people at risk of falls are worse off taking high doses of vitamin D, suggest the results of a study published in JAMA Internal Medicine on 4 January 2016, leading experts to recommend against high-dose supplementation.…
FDA approves URAT1 inhibitor lesinurad to treat gout A new treatment for gout that blocks the reabsorption of uric acid in the kidneys has been approved by the US Food and Drug Administration.…
Long-term inhaled corticosteroid use not linked to fracture risk in asthma Review offers reassurance over link between long-term use of inhaled corticosteroids and bone density.…
Spinal surgery: an overview Understanding the rationale for surgery and appropriate pharmaceutical care.…
Case study: management and counselling of a patient with rheumatoid arthritis Exploring questions to be considered when managing a patient with rheumatoid arthritis.…
Biosimilar medicines in rheumatology The long-term safety of biosimilar medicines is unknown, but while their use in rheumatology practice is supported, switching patients currently responding and tolerating the reference product is not.…